Hypoxic Non-Small-Cell Lung Cancer Cell-Secreted Exosomal microRNA-582-3p Drives Cancer Cell Malignant Phenotypes by Targeting Secreted Frizzled-Related Protein 1

References

• Arbour KC, Riely GJ. Systemic therapy for locally advanced and metastatic non-small cell lung cancer: a review. JAMA. 2019;322(8):764–774. doi:10.1001/jama.2019.1105831454018
   PubMed Web of Science ®Google Scholar
• Fitzmaurice C, Allen C, Barber RM, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–548. doi:10.1001/jamaoncol.2016.568827918777
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi:10.3322/caac.2144229313949
   PubMed Web of Science ®Google Scholar
• Riera-Domingo C, Audige A, Granja S, et al. Immunity, hypoxia, and metabolism-the menage a trois of cancer: implications for immunotherapy. Physiol Rev. 2020;100(1):1–102. doi:10.1152/physrev.00018.201931414610
   PubMed Web of Science ®Google Scholar
• Kakkad S, Krishnamachary B, Jacob D, et al. Molecular and functional imaging insights into the role of hypoxia in cancer aggression. Cancer Metastasis Rev. 2019;38(12):51–64. doi:10.1007/s10555-019-09788-330840168
   PubMedGoogle Scholar
• Macklin PS, McAuliffe J, Pugh CW, et al. Hypoxia and HIF pathway in cancer and the placenta. Placenta. 2017;56:8–13. doi:10.1016/j.placenta.2017.03.01028330647
   PubMed Web of Science ®Google Scholar
• Kalishwaralal K, Kwon WY. Exosomes for non-invasive cancer monitoring. Biotechnol J. 2019;14(1):e1800430. doi:10.1002/biot.20180043030358137
   PubMed Web of Science ®Google Scholar
• Milman N, Ginini L, Gil Z. Exosomes and their role in tumorigenesis and anticancer drug resistance. Drug Resist Updat. 2019;45:1–12. doi:10.1016/j.drup.2019.07.00331369918
   PubMed Web of Science ®Google Scholar
• Wortzel I, Dror S, Kenific CM, et al. Exosome-mediated metastasis: communication from a distance. Dev Cell. 2019;49(3):347–360. doi:10.1016/j.devcel.2019.04.01131063754
   PubMed Web of Science ®Google Scholar
• Graham K, Unger E. Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment. Int J Nanomed. 2018;13:6049–6058. doi:10.2147/ijn.s140462
   PubMed Web of Science ®Google Scholar
• Takahashi RU, Prieto-Vila M, Kohama I, et al. Development of miRNA-based therapeutic approaches for cancer patients. Cancer Sci. 2019;110(4):1140–1147. doi:10.1111/cas.1396530729639
   PubMed Web of Science ®Google Scholar
• Ghayad SE, Rammal G, Ghamloush F, et al. Exosomes derived from embryonal and alveolar rhabdomyosarcoma carry differential miRNA cargo and promote invasion of recipient fibroblasts. Sci Rep. 2016;6:37088. doi:10.1038/srep3708827853183
   PubMed Web of Science ®Google Scholar
• Wu H, Zhou J, Mei S, et al. Circulating exosomal microRNA-96 promotes cell proliferation, migration and drug resistance by targeting LMO7. J Cell Mol Med. 2017;21(6):1228–1236. doi:10.1111/jcmm.1305628026121
   PubMed Web of Science ®Google Scholar
• Li H, Tian X, Wang P, et al. MicroRNA-582-3p negatively regulates cell proliferation and cell cycle progression in acute myeloid leukemia by targeting cyclin B2. Cell Mol Biol Lett. 2019;24:66. doi:10.1186/s11658-019-0184-731844417
   PubMed Web of Science ®Google Scholar
• Fang L, Cai J, Chen B, et al. Aberrantly expressed miR-582-3p maintains lung cancer stem cell-like traits by activating Wnt/β-catenin signalling. Nat Commun. 2015;6:8640. doi:10.1038/ncomms964026468775
   PubMedGoogle Scholar
• Roma-Rodrigues C, Mendes R, Baptista PV, et al. Targeting tumor microenvironment for cancer therapy. Int J Mol Sci. 2019;20:4. doi:10.3390/ijms20040840
   Web of Science ®Google Scholar
• Redfern A, Agarwal V. Hypoxia as a signal for prison breakout in cancer. Curr Opin Clin Nutr Metab Care. 2019;22(4):250–263. doi:10.1097/mco.000000000000057731116106
   PubMed Web of Science ®Google Scholar
• Sruthi TV, Edatt L, Raji GR, et al. Horizontal transfer of miR-23a from hypoxic tumor cell colonies can induce angiogenesis. J Cell Physiol. 2018;233(4):3498–3514. doi:10.1002/jcp.2620228929578
   PubMed Web of Science ®Google Scholar
• Shao C, Yang F, Miao S, et al. Role of hypoxia-induced exosomes in tumor biology. Mol Cancer. 2018;17(1):120. doi:10.1186/s12943-018-0869-y30098600
   PubMedGoogle Scholar
• Blackwell RH, Foreman KE, Gupta GN. The role of cancer-derived exosomes in tumorigenicity & epithelial-to-mesenchymal transition. Cancers. 2017;9:8. doi:10.3390/cancers9080105
   PubMed Web of Science ®Google Scholar
• Kumar A, Deep G. Hypoxia in tumor microenvironment regulates exosome biogenesis: molecular mechanisms and translational opportunities. Cancer Lett. 2020;479:23–30. doi:10.1016/j.canlet.2020.03.01732201202
   PubMed Web of Science ®Google Scholar
• Hu C, Meiners S, Lukas C, et al. Role of exosomal microRNAs in lung cancer biology and clinical applications. Cell Prolif. 2020:e12828. doi:10.1111/cpr.12828.32391938
   PubMed Web of Science ®Google Scholar
• Tang Y, Cui Y, Li Z, et al. Radiation-induced miR-208a increases the proliferation and radioresistance by targeting p21 in human lung cancer cells. J Exp Clin Cancer Res. 2016;35:7. doi:10.1186/s13046-016-0285-326754670
   PubMed Web of Science ®Google Scholar
• Wei F, Ma C, Zhou T, et al. Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p. Mol Cancer. 2017;16(1):132. doi:10.1186/s12943-017-0694-828743280
   PubMed Web of Science ®Google Scholar
• Hsu YL, Hung JY, Chang WA, et al. Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1. Oncogene. 2017;36(34):4929–4942. doi:10.1038/onc.2017.10528436951
   PubMed Web of Science ®Google Scholar
• Dong C, Liu X, Wang H, et al. Hypoxic non-small-cell lung cancer cell-derived exosomal miR-21 promotes resistance of normoxic cell to cisplatin. Onco Targets Ther. 2019;12:1947–1956. doi:10.2147/ott.s18692230881046
   PubMed Web of Science ®Google Scholar
• Bobowicz M, Skrzypski M, Czapiewski P, et al. Prognostic value of 5-microRNA based signature in T2-T3N0 colon cancer. Clin Exp Metastasis. 2016;33(8):765–773. doi:10.1007/s10585-016-9810-127485175
   PubMed Web of Science ®Google Scholar
• Butz H, Liko I, Czirjak S, et al. MicroRNA profile indicates downregulation of the TGFbeta pathway in sporadic non-functioning pituitary adenomas. Pituitary. 2011;14(2):112–124. doi:10.1007/s11102-010-0268-x21063788
   PubMed Web of Science ®Google Scholar
• Huang S, Zou C, Tang Y, et al. miR-582-3p and miR-582-5p suppress prostate cancer metastasis to bone by repressing TGF-beta signaling. Mol Ther Nucleic Acids. 2019;16:91–104. doi:10.1016/j.omtn.2019.01.00430852380
   PubMedGoogle Scholar
• Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16(3):203–222. doi:10.1038/nrd.2016.24628209991
   PubMed Web of Science ®Google Scholar
• Schafer SA, Hulsewig C, Barth P, et al. Correlation between SFRP1 expression and clinicopathological parameters in patients with triple-negative breast cancer. Future Oncol. 2019;15(16):1921–1938. doi:10.2217/fon-2018-056431140870
   PubMed Web of Science ®Google Scholar
• Regel I, Eichenmuller M, Mahajan UM, et al. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations. J Cancer Res Clin Oncol. 2020;146(5):1153–1167. doi:10.1007/s00432-020-03182-132189106
   PubMed Web of Science ®Google Scholar
• Sunkara RR, Sarate RM, Setia P, et al. SFRP1 in skin tumor initiation and cancer stem cell regulation with potential implications in epithelial cancers. Stem Cell Reports. 2020;14(2):271–284. doi:10.1016/j.stemcr.2019.12.00631928951
   PubMed Web of Science ®Google Scholar